176 related articles for article (PubMed ID: 28025744)
1. Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease.
Yablecovitch D; Oren A; Ben-Horin S; Fudim E; Eliakim R; Saker T; Konikoff FM; Kopylov U; Matthias T; Lerner A
Dig Dis Sci; 2017 Mar; 62(3):755-760. PubMed ID: 28025744
[TBL] [Abstract][Full Text] [Related]
2. Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.
Vorobjova T; Uibo O; Heilman K; Uibo R
World J Gastroenterol; 2015 Jan; 21(2):439-52. PubMed ID: 25593459
[TBL] [Abstract][Full Text] [Related]
3. The degree of mucosal damage to the small intestine and serum immunoglobulin G4 levels correlate with celiac disease.
Demirci H; Polat Z; Ozturk K; Kekilli M; Kantarcioglu M; Sahiner F; Uygun A; Bagci S
Eur J Gastroenterol Hepatol; 2015 Jul; 27(7):781-4. PubMed ID: 25856692
[TBL] [Abstract][Full Text] [Related]
4. Soluble Syndecan-1 Levels Are Elevated in Patients with Inflammatory Bowel Disease.
Yablecovitch D; Stein A; Shabat-Simon M; Naftali T; Gabay G; Laish I; Oren A; Konikoff FM
Dig Dis Sci; 2015 Aug; 60(8):2419-26. PubMed ID: 25702042
[TBL] [Abstract][Full Text] [Related]
5. IgA anti-actin antibodies in children with celiac disease: comparison of immunofluorescence with Elisa assay in predicting severe intestinal damage.
Bazzigaluppi E; Parma B; Tronconi GM; Corsin P; Albarello L; Mora S; Barera G
Ital J Pediatr; 2010 Mar; 36():25. PubMed ID: 20298549
[TBL] [Abstract][Full Text] [Related]
6. Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease.
Borrelli M; Salvati VM; Maglio M; Zanzi D; Ferrara K; Santagata S; Ponticelli D; Aitoro R; Mazzarella G; Lania G; Gianfrani C; Auricchio R; Troncone R
Am J Gastroenterol; 2013 Nov; 108(11):1775-84. PubMed ID: 24060758
[TBL] [Abstract][Full Text] [Related]
7. Additional value of serum I-FABP levels for evaluating celiac disease activity in children.
Vreugdenhil AC; Wolters VM; Adriaanse MP; Van den Neucker AM; van Bijnen AA; Houwen R; Buurman WA
Scand J Gastroenterol; 2011 Dec; 46(12):1435-41. PubMed ID: 22029621
[TBL] [Abstract][Full Text] [Related]
8. Degree of damage to the small bowel and serum antibody titers correlate with clinical presentation of patients with celiac disease.
Taavela J; Kurppa K; Collin P; Lähdeaho ML; Salmi T; Saavalainen P; Haimila K; Huhtala H; Laurila K; Sievänen H; Mäki M; Kaukinen K
Clin Gastroenterol Hepatol; 2013 Feb; 11(2):166-71.e1. PubMed ID: 23063678
[TBL] [Abstract][Full Text] [Related]
9. Can celiac serology alone be used as a marker of duodenal mucosal recovery in children with celiac disease on a gluten-free diet?
Bannister EG; Cameron DJ; Ng J; Chow CW; Oliver MR; Alex G; Catto-Smith AG; Heine RG; Webb A; McGrath K; Simpson D; Hardikar W
Am J Gastroenterol; 2014 Sep; 109(9):1478-83. PubMed ID: 25070050
[TBL] [Abstract][Full Text] [Related]
10. A pilot study on the noninvasive evaluation of intestinal damage in celiac disease using I-FABP and L-FABP.
Derikx JP; Vreugdenhil AC; Van den Neucker AM; Grootjans J; van Bijnen AA; Damoiseaux JG; van Heurn LW; Heineman E; Buurman WA
J Clin Gastroenterol; 2009 Sep; 43(8):727-33. PubMed ID: 19359998
[TBL] [Abstract][Full Text] [Related]
11. Early developing celiac disease in children with cerebral palsy.
Stenberg R; Kaukinen K; Bengtsson M; Lindberg E; Dahle C
J Pediatr Gastroenterol Nutr; 2011 Dec; 53(6):674-8. PubMed ID: 21697743
[TBL] [Abstract][Full Text] [Related]
12. IgA antigliadin antibodies in childhood celiac disease.
Dinari G; Rosenbach Y; Marcus H; Nitzan M; Zahavi I
Isr J Med Sci; 1988 Jun; 24(6):286-90. PubMed ID: 3403224
[TBL] [Abstract][Full Text] [Related]
13. Mucosal healing in children with treated celiac disease.
Ghazzawi Y; Rubio-Tapia A; Murray JA; Absah I
J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):229-31. PubMed ID: 24691402
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of endoscopic small intestinal biopsies in children with coeliac disease.
Magliocca FM; Bonamico M; Petrozza V; Danesi H; Liuzzi M; Velucci O; Carpino F
Ital J Anat Embryol; 2001; 106(2 Suppl 1):329-35. PubMed ID: 11729974
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic yield of capsule endoscopy in refractory celiac disease.
Barret M; Malamut G; Rahmi G; Samaha E; Edery J; Verkarre V; Macintyre E; Lenain E; Chatellier G; Cerf-Bensussan N; Cellier C
Am J Gastroenterol; 2012 Oct; 107(10):1546-53. PubMed ID: 22964554
[TBL] [Abstract][Full Text] [Related]
16. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study.
Kurppa K; Collin P; Viljamaa M; Haimila K; Saavalainen P; Partanen J; Laurila K; Huhtala H; Paasikivi K; Mäki M; Kaukinen K
Gastroenterology; 2009 Mar; 136(3):816-23. PubMed ID: 19111551
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonographic assessment of celiac disease in children: comparison with antiendomysium antibodies and histology.
Micetić-Turk D; Umek-Bradac S; Dolinsek J; Gorenjak M; Turk Z; Skalicky M
Wien Klin Wochenschr; 2001; 113 Suppl 3():27-31. PubMed ID: 15503617
[TBL] [Abstract][Full Text] [Related]
18. How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease.
Ravelli A; Villanacci V; Monfredini C; Martinazzi S; Grassi V; Manenti S
Am J Gastroenterol; 2010 Sep; 105(9):2103-10. PubMed ID: 20372112
[TBL] [Abstract][Full Text] [Related]
19. Serum and intestinal dipeptidyl peptidase IV (DPP IV/CD26) activity in children with celiac disease.
Detel D; Persić M; Varljen J
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):65-70. PubMed ID: 17592366
[TBL] [Abstract][Full Text] [Related]
20. Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening.
Webb C; Norström F; Myléus A; Ivarsson A; Halvarsson B; Högberg L; Lagerqvist C; Rosén A; Sandström O; Stenhammar L; Carlsson A
J Pediatr Gastroenterol Nutr; 2015 Jun; 60(6):787-91. PubMed ID: 25564816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
